UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Response to Brigatinib Targeted Therapy in Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 19 Deletion, T790M, and cis-C797S Triple Mutations: A Case Report

International journal of molecular sciences, 2022-12, Vol.24 (1), p.602

2022

Volltextzugriff (PDF)

Systemic Anticoagulation and Inpatient Outcomes of Pancreatic Cancer: Real-World Evidence from U.S. Nationwide Inpatient Sample

Cancers, 2023-03, Vol.15 (7), p.1985

2023

Volltextzugriff (PDF)

Beta2-microglobulin is a valuable marker and identifies a poor-prognosis subgroup among intermediate-risk patients with diffuse large B cell lymphoma

Clinical and experimental medicine, 2023-11, Vol.23 (7), p.3759-3766

2023

Volltextzugriff (PDF)

Comprehensive Evaluation of Immune-Checkpoint DNA Cancer Vaccines in a Rat Cholangiocarcinoma Model

Vaccines (Basel), 2020-11, Vol.8 (4), p.703

2020

Volltextzugriff (PDF)

P1519: MULTICENTER STUDY OF SARS‐COV‐2 INFECTION IN PATIENTS WITH HEMATOLOGICAL DISEASE: VACCINATION, ANTIVIRAL THERAPY, RISK FACTORS, AND OUTCOMES IN TAIWAN

HemaSphere, 2023-08, Vol.7 (S3), p.e13238b4-n/a

2023

Volltextzugriff (PDF)

Correction: Huang et al. Systemic Anticoagulation and Inpatient Outcomes of Pancreatic Cancer: Real-World Evidence from U.S. Nationwide Inpatient Sample. Cancers 2023, 15 , 1985

Cancers, 2024-03, Vol.16 (6), p.1181

2024

Volltextzugriff (PDF)

Major impact of prognosis by age and sex in patients with primary mediastinal large B‑cell lymphoma

Oncology letters, 2024-02, Vol.27 (2), Article 57

2024

Volltextzugriff (PDF)

Clinical Features of Testicular Lymphoma

Acta haematologica, 2014-01, Vol.131 (3), p.187-192

2014

Volltextzugriff (PDF)

Correction: Huang et al. Systemic Anticoagulation and Inpatient Outcomes of Pancreatic Cancer: Real-World Evidence from U.S. Nationwide Inpatient Sample. ICancers/I 2023, I15/I, 1985

Cancers, 2024-03, Vol.16 (6)

2024

Volltextzugriff (PDF)

A multicenter, phase Ib/2 study of varlitinib plus gemcitabine and cisplatin (gem/cis) for treatment of naïve, advanced, or metastatic biliary tract cancer (BTC)

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.319-319

2019

Volltextzugriff (PDF)

Preliminary Results of a Phase 2a Dose Optimization Study of ASLAN003 (DHODH inhibitor) in Acute Myeloid Leukemia (AML) Patients Who Are Ineligible for Standard Therapy; Early Signs of Activity

Blood, 2018-11, Vol.132 (Supplement 1), p.2676-2676

2018

Volltextzugriff (PDF)

Clonal Leukemic Evolution In Myelodysplastic Syndromes With ASXL1 and EZH2 mutations: A Comparative Analysis Of 58 Paired Samples

Blood, 2013-11, Vol.122 (21), p.2786-2786

2013

Volltextzugriff (PDF)

AB063. P-34. A multicenter, phase 1b/2 study of varlitinib plus gemcitabine and cisplatin (gem/cis) for treatment naïve advanced or metastatic biliary tract cancer (BTC)

Hepatobiliary surgery and nutrition, 2019-03, Vol.8 (S1), p.AB063-AB063

2019

Volltextzugriff (PDF)

Response to Brigatinib Targeted Therapy in Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 19 Deletion, T790M, and cis-C797S Triple Mutations: A Case Report

International journal of molecular sciences, 2022, Vol.24 (1)

2022

Volltextzugriff (PDF)

Evaluating the Potential of Machine Learning and Wearable Devices in End-of-Life Care in Predicting 7-Day Death Events Among Patients With Terminal Cancer: Cohort Study

Journal of medical Internet research, 2023-08, Vol.25 (1), p.e47366-e47366

2023

Volltextzugriff (PDF)

Dual Delivery of HNF4α and Cisplatin by Mesoporous Silica Nanoparticles Inhibits Cancer Pluripotency and Tumorigenicity in Hepatoma-Derived CD133-Expressing Stem Cells

ACS applied materials & interfaces, 2019-06, Vol.11 (22), p.19808-19818

2019

Volltextzugriff (PDF)

Dual delivery of siRNA and plasmid DNA using mesoporous silica nanoparticles to differentiate induced pluripotent stem cells into dopaminergic neurons

Journal of materials chemistry. B, Materials for biology and medicine, 2017-04, Vol.5 (16), p.3012-3023

2017

Volltextzugriff (PDF)

Generation of Functional Dopaminergic Neurons from Reprogramming Fibroblasts by Nonviral-based Mesoporous Silica Nanoparticles

Scientific reports, 2018-01, Vol.8 (1), p.11-11, Article 11

2018

Volltextzugriff (PDF)

Developing a machine learning-based short form of the positive and negative syndrome scale

Asian journal of psychiatry, 2024-04, Vol.94, p.103965-103965, Article 103965

2024

Volltextzugriff (PDF)

Photo-Catalytic Activity of Different Thicknesses TiO2/SnO2 Double Layer Nano Composite Thin Films

Materials transactions, 2009-09, Vol.50 (9), p.2329-2334

2009

Volltextzugriff (PDF)

Perioperative thrombotic occlusion of left external iliac artery during anterior lumbar interbody fusion

Archives of orthopaedic and trauma surgery, 2008-10, Vol.128 (10), p.1107-1110

2008

Volltextzugriff (PDF)

Risk Factors Affecting Adverse Outcomes of Cardiac Surgery in Patients Aged 70 Years and Older

Acta Anaesthesiologica Taiwanica, 2007-12, Vol.45 (4), p.197-204

2007

Volltextzugriff (PDF)

Massive Pulmonary Embolism during Orthopedic Surgery

Acta Anaesthesiologica Taiwanica, 2007-06, Vol.45 (2), p.117-120

2007

Volltextzugriff (PDF)

Dual delivery of siRNA and plasmid DNA using mesoporous silica nanoparticles to differentiate induced pluripotent stem cells into dopaminergic neuronsElectronic supplementary information (ESI) available: More characterization techniques (gel electrophoresis, cell viability, immunofluorescence staining, and flow cytometry analysis) and tables for flow cytometry analysis. See DOI: 10.1039/c7tb00351j

2017-04

Volltextzugriff (PDF)

Elimination of Hepatitis C Virus in a Dialysis Population: A Collaborative Care Model in Taiwan

American journal of kidney diseases, 2021-10, Vol.78 (4), p.511-519.e1

2021

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(22)

Publikationsform

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Response to Brigatinib Targeted Therapy in Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 19 Deletion, T790M, and cis-C797S Triple Mutations: A Case Report

Systemic Anticoagulation and Inpatient Outcomes of Pancreatic Cancer: Real-World Evidence from U.S. Nationwide Inpatient Sample

Beta2-microglobulin is a valuable marker and identifies a poor-prognosis subgroup among intermediate-risk patients with diffuse large B cell lymphoma

Comprehensive Evaluation of Immune-Checkpoint DNA Cancer Vaccines in a Rat Cholangiocarcinoma Model

P1519: MULTICENTER STUDY OF SARS‐COV‐2 INFECTION IN PATIENTS WITH HEMATOLOGICAL DISEASE: VACCINATION, ANTIVIRAL THERAPY, RISK FACTORS, AND OUTCOMES IN TAIWAN

Correction: Huang et al. Systemic Anticoagulation and Inpatient Outcomes of Pancreatic Cancer: Real-World Evidence from U.S. Nationwide Inpatient Sample. Cancers 2023, 15 , 1985

Major impact of prognosis by age and sex in patients with primary mediastinal large B‑cell lymphoma

Clinical Features of Testicular Lymphoma

Correction: Huang et al. Systemic Anticoagulation and Inpatient Outcomes of Pancreatic Cancer: Real-World Evidence from U.S. Nationwide Inpatient Sample. ICancers/I 2023, I15/I, 1985

A multicenter, phase Ib/2 study of varlitinib plus gemcitabine and cisplatin (gem/cis) for treatment of naïve, advanced, or metastatic biliary tract cancer (BTC)

Preliminary Results of a Phase 2a Dose Optimization Study of ASLAN003 (DHODH inhibitor) in Acute Myeloid Leukemia (AML) Patients Who Are Ineligible for Standard Therapy; Early Signs of Activity

Clonal Leukemic Evolution In Myelodysplastic Syndromes With ASXL1 and EZH2 mutations: A Comparative Analysis Of 58 Paired Samples

AB063. P-34. A multicenter, phase 1b/2 study of varlitinib plus gemcitabine and cisplatin (gem/cis) for treatment naïve advanced or metastatic biliary tract cancer (BTC)

Response to Brigatinib Targeted Therapy in Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 19 Deletion, T790M, and cis-C797S Triple Mutations: A Case Report

Evaluating the Potential of Machine Learning and Wearable Devices in End-of-Life Care in Predicting 7-Day Death Events Among Patients With Terminal Cancer: Cohort Study

Dual Delivery of HNF4α and Cisplatin by Mesoporous Silica Nanoparticles Inhibits Cancer Pluripotency and Tumorigenicity in Hepatoma-Derived CD133-Expressing Stem Cells

Dual delivery of siRNA and plasmid DNA using mesoporous silica nanoparticles to differentiate induced pluripotent stem cells into dopaminergic neurons

Generation of Functional Dopaminergic Neurons from Reprogramming Fibroblasts by Nonviral-based Mesoporous Silica Nanoparticles

Developing a machine learning-based short form of the positive and negative syndrome scale

Photo-Catalytic Activity of Different Thicknesses TiO2/SnO2 Double Layer Nano Composite Thin Films

Perioperative thrombotic occlusion of left external iliac artery during anterior lumbar interbody fusion

Risk Factors Affecting Adverse Outcomes of Cardiac Surgery in Patients Aged 70 Years and Older

Massive Pulmonary Embolism during Orthopedic Surgery

Elimination of Hepatitis C Virus in a Dialysis Population: A Collaborative Care Model in Taiwan

Suchergebnisse filtern